Finance

Beta
Lists
HOWL:NASDAQ
Werewolf Therapeutics Inc
$0.37
-1.94%
(-0.0074) 1D
$0.39
+4.14% (+0.015)
After hours
Closed: Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HOWL...
Open
$0.37
High
$0.39
Low
$0.36
Mkt. cap
18.29M
Avg. vol.
603.07K
Volume
0.00
52-wk high
$2.38
52-wk low
$0.36
EPS
-$1.21
Beta
0.29
Shares outstanding
48.60M
No. of employees
14
Open
$0.37
High
$0.39
Low
$0.36
Mkt. cap
18.29M
Avg. vol.
603.07K
Volume
0.00
52-wk high
$2.38
52-wk low
$0.36
EPS
-$1.21
Beta
0.29
Shares outstanding
48.60M
No. of employees
14
News stories
From sources across the web
About Werewolf Therapeutics Inc
CEO-
Employees14
Founded2017
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitewerewolftx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.28 / -$0.30
+5.08%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
973.00K
10.86M
6.18M
-
Cost of revenue
973.00K
10.86M
6.18M
-
Research and development expenses
11.39M
-
-
8.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.18M
4.86M
3.24M
5.09M
Operating expense
16.57M
4.86M
3.24M
13.27M
Total operating expenses
17.54M
15.73M
9.42M
13.27M
Operating income
-17.54M
-15.73M
-9.42M
-13.27M
Other non operating income
11.00K
-
1.84M
674.00K
EBT including unusual items
-17.98M
-16.37M
-8.38M
-13.53M
EBT excluding unusual items
-17.98M
-16.37M
-8.38M
-13.53M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.98M
-16.37M
-8.38M
-13.53M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.36
-0.17
-0.28
Interest and investment income
850.00K
697.00K
564.00K
433.00K
Interest expense
-1.30M
-1.34M
-1.37M
-1.37M
Net interest expenses
-451.00K
-644.00K
-805.00K
-935.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.14M
-15.32M
-9.02M
-12.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer